A seven-gene prognostic model for platinum-treated ovarian carcinomas. - Wikidata - wikimedia - TriplyDB

A seven-gene prognostic model for platinum-treated ovarian carcinomas.

A seven-gene prognostic model for platinum-treated ovarian carcinomas.

http://www.wikidata.org/entity/Q35125629

about

Comparative meta-analysis of prognostic gene signatures for late-stage ovarian cancer Integrated analysis of gene expression profiles associated with response of platinum/paclitaxel-based treatment in epithelial ovarian cancer Single Gene Prognostic Biomarkers in Ovarian Cancer: A Meta-Analysis.Prediction of resistance to chemotherapy in ovarian cancer: a systematic review.Risk prediction for late-stage ovarian cancer by meta-analysis of 1525 patient samples.Risk prediction model for epithelial ovarian cancer using molecular markers and clinical characteristics.Identification of Cathepsin K in the Peritoneal Metastasis of Ovarian Carcinoma Using In-silico, Gene Expression Analysis Prognostic biomarkers in endometrial and ovarian carcinoma.Ovarian cancer: diagnostic, biological and prognostic aspects.Frontline treatment of epithelial ovarian cancer.Copy number changes of 4-gene set may predict early relapse in advanced epithelial ovarian cancer after initial platinum-paclitaxel chemotherapy.The rise of genomic profiling in ovarian cancer.

P2860

Q26859166-F382C0EE-DDDE-4224-9908-4AD484B1FD02 Q28484592-EA1A7312-8D17-4546-95BC-E9D1F5FB171C Q34514528-F3042DE3-6373-4E96-9772-6D5B4E82AEB9 Q35212386-8A06F10B-39B6-4CF5-B6A4-1948FDB29B7D Q36087199-E4960F37-F388-470E-8E73-58D35E73A47D Q36199823-02F0D84E-A7AC-4FD0-AD53-7B70BAFAD755 Q36792370-EDC059C7-9FC9-4FE2-93ED-70A1324B7F8E Q38185940-0EB67BA1-D292-4698-BA99-53AB69AB067B Q38261795-9E3D3493-E950-457E-98A3-271CFD7F336A Q38669746-C3D2B581-308D-4D9F-ABE4-22E38AA705AC Q40950661-59A3AEDE-F9B6-4425-8C37-D8F4AA39CC00 Q50345037-6C11F737-BC52-40FC-8BD0-BEF951F78138

P2860

A seven-gene prognostic model for platinum-treated ovarian carcinomas.

http://www.wikidata.org/entity/Q35125629

description

2011 nî lūn-bûn

@nan

2011 թուականի Յունիսին հրատարակուած գիտական յօդուած

@hyw

2011 թվականի հունիսին հրատարակված գիտական հոդված

@hy

2011年の論文

@ja

2011年論文

@yue

2011年論文

@zh-hant

2011年論文

@zh-hk

2011年論文

@zh-mo

2011年論文

@zh-tw

2011年论文

@wuu

name

A seven-gene prognostic model for platinum-treated ovarian carcinomas.

@ast

A seven-gene prognostic model for platinum-treated ovarian carcinomas.

@en

type

label

A seven-gene prognostic model for platinum-treated ovarian carcinomas.

@ast

A seven-gene prognostic model for platinum-treated ovarian carcinomas.

@en

prefLabel

A seven-gene prognostic model for platinum-treated ovarian carcinomas.

@ast

A seven-gene prognostic model for platinum-treated ovarian carcinomas.

@en

P1433

Q35125629-2BB38A1D-BFAC-416A-85FD-760A99D96B2D

P1476

Q35125629-101CDB91-5DD2-43E1-ABF8-35C5D10ABF9C

P2093

Q35125629-2017D117-9B18-4017-BC57-4546FB12D40A

Q35125629-2154BA80-8473-4CEE-AAE6-2F275E145E8F

Q35125629-26D6AE71-C077-4A82-AF41-81DC7DE20537

Q35125629-5BD52FD4-A0F0-4196-A6A2-4A639D9E2FF1

Q35125629-5EF26F3A-E04E-4D0C-991C-1F26BED1968D

Q35125629-6119B3BB-837C-4DB3-A877-0170F828070A

Q35125629-76A30B47-EA79-4962-8B16-FE51CBADB789

Q35125629-BC255520-EB32-40A9-B809-2364B181EE94

Q35125629-DCEDAB12-AB77-464F-AD01-AA6AA3C20D8F

P2860

Q35125629-04A9C31A-F4E9-43D6-BD33-3AC34A17B038

Q35125629-182A5B51-AF65-4F68-B654-2CA745E4957D

Q35125629-1F0C7366-F0A9-4D38-B1DE-9D954B2956F0

Q35125629-1FBA6960-3DB0-4ACB-8136-3CC8FD5BB949

Q35125629-20D32879-9200-46D9-9357-2F219CA3BFAB

Q35125629-24038A67-1927-4168-9261-C28BAAAD4778

Q35125629-2582DB76-E531-41A0-A52E-7E3E6212339B

Q35125629-29759705-7B1D-45D9-8201-A0EBA99BC67F

Q35125629-2D2F890B-0852-4822-8231-6BD42D9E102A

Q35125629-39D15CE4-00E1-49C6-B808-3FDFA2D7BB25

P2888

Q35125629-41D01D88-D95E-46B5-AB69-A1EBDA9221A0

P304

Q35125629-47484CCC-F3E1-41E2-A919-BF24A478D427

P31

Q35125629-8CA3BEDB-07C2-4877-AAB0-CD20B1005592

P356

Q35125629-268BAC55-593A-42E7-907D-EAFF425CFE78

P407

Q35125629-2DF6A8FC-4323-44AE-BF13-E8CDA549A310

P433

Q35125629-3A81ECB2-BD8C-4252-930C-13F6745E43DD

P478

Q35125629-5F098C46-32A5-4608-BD33-0E123E12DD5C

P577

Q35125629-232B4223-B276-478E-B696-B76924622B72

P5875

Q35125629-8B0C9702-5C0D-4799-B77A-D54F43BAE05D

P6179

Q35125629-FB1D435D-64D3-4574-82B9-C29997ECD2A5

P698

Q35125629-CD4D03EB-D1A6-47D5-882A-1D09785A84FF

P932

Q35125629-1DE2E270-46BF-4419-ABEB-DC65A634EB41

P356

P1433

British Journal of Cancer

P1476

A seven-gene prognostic model for platinum-treated ovarian carcinomas.

@en

P2093

D Birnbaum

http://www.w3.org/2001/XMLSchema#string

E Lambaudie

http://www.w3.org/2001/XMLSchema#string

F Bertucci

http://www.w3.org/2001/XMLSchema#string

J Adelaide

http://www.w3.org/2001/XMLSchema#string

J Bonensea

http://www.w3.org/2001/XMLSchema#string

J Jacquemier

http://www.w3.org/2001/XMLSchema#string

P Finetti

http://www.w3.org/2001/XMLSchema#string

P Viens

http://www.w3.org/2001/XMLSchema#string

R Sabatier

http://www.w3.org/2001/XMLSchema#string

P2860

Proteomic analysis identifies MMP-9, DJ-1 and A1BG as overexpressed proteins in pancreatic juice from pancreatic ductal adenocarcinoma patients

A novel transmembrane serine protease (TMPRSS3) overexpressed in pancreatic cancer

Gene expression patterns in ovarian carcinomas

Oncogenic pathway signatures in human cancers as a guide to targeted therapies

Isolation from opossum serum of a metalloproteinase inhibitor homologous to human alpha 1B-glycoprotein.

Phase III trial of carboplatin and paclitaxel compared with cisplatin and paclitaxel in patients with optimally resected stage III ovarian cancer: a Gynecologic Oncology Group study.

Novel molecular subtypes of serous and endometrioid ovarian cancer linked to clinical outcome.

A prognostic gene expression index in ovarian cancer - validation across different independent data sets.

Paclitaxel plus carboplatin versus standard chemotherapy with either single-agent carboplatin or cyclophosphamide, doxorubicin, and cisplatin in women with ovarian cancer: the ICON3 randomised trial.

Survival effect of maximal cytoreductive surgery for advanced ovarian carcinoma during the platinum era: a meta-analysis.

P2888

P304

304-311

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1038/BJC.2011.219

http://www.w3.org/2001/XMLSchema#string

P407

P433

2

http://www.w3.org/2001/XMLSchema#string

P478

105

http://www.w3.org/2001/XMLSchema#string

P577

2011-06-07T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

51202768

http://www.w3.org/2001/XMLSchema#string

P6179

1007934234

http://www.w3.org/2001/XMLSchema#string

P698

21654678

http://www.w3.org/2001/XMLSchema#string

P932

3142802

http://www.w3.org/2001/XMLSchema#string